Regarding depressive disorders, one study was able to demonstrate that the lower the patients’ oxytocin, the lower their degree of change in depression over the course of a cognitive behavioural analysis system of therapy (CBASP) program [64]. This evidence concerns the gene OXT and major depressive disorder.